Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you are taking Mounjaro and trying to conceive, or you have just found out you are pregnant, the guidance is clear: tirzepatide is not recommended during pregnancy, when trying to get pregnant, or while breastfeeding. Stop treatment and speak to your GP or specialist before your next dose. The rest of this page explains what is known, what is less certain, and what to do next.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
That pen sitting on the fridge door next to the orange juice needs to stay there, unused. The practical step is straightforward: stop taking Mounjaro now and contact your GP or midwife today. Do not wait until your next scheduled injection. Tirzepatide is not licensed for use in pregnancy, and current clinical guidance recommends discontinuing it as soon as pregnancy is confirmed or suspected.
Animal studies have raised concerns about developmental effects at high doses, though what this means for humans is not yet fully established. Because the evidence base in pregnant women is so limited, the cautious position (stopping immediately) is the right one. Your GP will want to know your dose, how long you have been taking it, and the date of your last injection. That information helps them assess timing and support your care through the pregnancy. For a fuller picture of what is known about Mounjaro use in early pregnancy, the Mounjaro and pregnancy overview covers the available evidence in detail.
One thing that sometimes catches people off guard: tirzepatide has a half-life of roughly five days, so it clears the body gradually rather than instantly after stopping. That does not change the advice (stop now) but it is worth understanding so you can give your healthcare team an accurate history.
A significant number of women find that weight loss on tirzepatide changes their reproductive picture in ways they did not anticipate. For women living with polycystic ovary syndrome, for example, even modest weight reduction can restore regular ovulation. NHS guidance on tirzepatide on the NHS medicines pages notes that effective contraception is important for this reason: fertility may improve before it is obvious it has.
If you are planning a pregnancy, the recommendation is to stop Mounjaro before you begin trying. The MHRA advises using contraception throughout treatment and for a wash-out period before trying to conceive, your prescriber or GP can advise on the specific timing in your case, since it will depend on how long you have been on the medicine and your wider health picture. If you are wondering whether Mounjaro can stop you from getting pregnant, that page looks at the relationship between the medicine and fertility in more detail. The question of whether you can get pregnant while on Mounjaro is worth exploring if you want more detail on the fertility and conception side of this.
It is also worth knowing that Mounjaro's effect on oral contraceptive absorption adds a layer of complexity. During the first four weeks of treatment and for four weeks after each dose increase, the pill may be less reliably absorbed. NHS England's guidance on weight-management injections is explicit on this point: add a barrier method during those windows. This does not mean the pill stops working entirely, but the margin narrows enough that the precaution is sensible.
Stopping Mounjaro does not mean your progress disappears overnight, though some appetite and weight change is common when the medicine is discontinued. That is a conversation worth having with your GP well in advance if you are planning a pregnancy rather than responding to a surprise. For women who are not yet ready to conceive, the full Mounjaro treatment page covers what private treatment involves and how clinical review works at every stage.
For context on why Mounjaro is prescribed in the first place (and what the broader weight-management options look like) the weight-loss treatment overview is a useful reference. If you have questions about eligibility for private treatment after a pregnancy, or want to understand what becoming pregnant while taking Mounjaro means for your treatment and next steps, that page addresses those practical questions directly. It is also worth noting that Mounjaro is not suitable for younger patients, and the guidance on Mounjaro for under-18s explains why the medicine is not recommended for anyone below that age threshold.
At nume, sorry, at our clinic, every repeat prescription involves a fresh clinical review. That means if your circumstances change (including a pregnancy, a planned conception, or a change in contraception) your prescriber is the right person to contact before your next pen arrives. You can also reach the team through the support page any day of the week. And if you want to know what clinical review looks like in practice, our lead prescriber's profile gives a sense of how oversight works here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.